Cited by 70Antifungal resistance and susceptibilityFungal Infections and StudiesOcular Infections and Treatments

Candidemia Before and During the Fluconazole Era: Prevalence, Type of Species and Approach to Treatment in a Tertiary Care Community Hospital

Joseph Baran Jr, Bopanna Muckatira, Riad Khatib·2001·Scandinavian Journal of Infectious Diseases

Abstract

The characteristics of candidemia before and after the introduction of fluconazole were compared at our institution. In the pre-fluconazole era (1986-89), the incidence of candidemia rose from 0.02% to 13% over the course of 4 y. Candida albicans accounted for 44/66 isolates (67%) and C. glabrata and C. parapsilosis were the predominant non-albicans species (9% each). In one-third of cases antifungal therapy was not given and the overall mortality rate was 55%. During the fluconazole era (1994-97), the incidence of candidemia remained constant between 1994 and 1996 at 0.09-0.11% and dropped to 0.06% in 1997. Bloodstream infection associated with neutropenia increased significantly but only accounted for 13% of cases; antifungal prophylaxis was not employed. The isolation of C. albicans decreased (n = 49; 50%) whereas isolation of both C. parapsilosis (n = 23; 24%) and C. tropicalis (n = 16; 16%) increased. The vast majority of patients received antifungal therapy and the overall mortality rate was 39%. These findings show that the incidence of candidemia rose steadily prior to the fluconazole era and then stabilized in spite of a shift towards non-albicans species. When candidemia was encountered in the fluconazole era, it was rare not to give antifungal treatment.

Integrity signals

Registry

Crossref · 10.1080/003655401750065544

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Non-albicans species of Candida are increasingly associated with invasive candidiasis.

    “Although Candida albicans remains the most common pathogen in oropharyngeal and cutaneous candidiasis, non-albicans species of Candida are increasingly associated with invasive candidiasis [1][2][3][4][5].”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [3]

  • Optimization of in vitro susceptibility testing of echinocandins against Candida spp. has been difficult.

    “The optimization of in vitro susceptibility testing of the echinocandins against Candida spp. has been difficult (18, 177, 213);”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Joseph Baran Jr, B. M.
Affiliations
John Hospital and Medical Center
Venue
Scandinavian Journal of Infectious Diseases
Published
2001-01
Volume
33
Issue
2
Pages
137-139
ISSN
  • 0036-5548 (ISSN-L)
  • 1651-1980
OpenAlex
W2158730440
Cited by
70
References
7
Citations by year
2025: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2016: 2 · 2015: 2 · 2014: 6 · 2012: 3
FWCI
5.11
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
candidemia, fluconazole, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida glabrata, candidemia incidence, antifungal therapy, mortality, antifungal prophylaxis, non-albicans Candida
MeSH terms
Adolescent, Adult, Aged, Antifungal Agents, Candida, Candidiasis, Child, Child, Preschool, Drug Utilization, Hospitals, Community, Hospitals, Teaching, Humans, Infant, Middle Aged, Opportunistic Infections, Fluconazole, Incidence, Prevalence, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review